Symphony Financial’s Hologic HOLX Stock Holding History

Symphony Financial’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,414	Closed	-$479K	–	176
2021 Q1	$479K	Buy	+6,414	New	+$487K	0.13%	117

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Symphony Financial's HOLX Position: Q2 2021 in Review

Symphony Financial sold out of Hologic (HOLX) in Q2 2021, closing a stake of 6,414 shares — an estimated $479K sold.

Symphony Financial first reported a position in HOLX in Q1 2021 and held it in 1 quarter. The position peaked at $479K in Q1 2021. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

Symphony Financial reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
Symphony Financial sold 6,414 Hologic shares in Q2 2021, an estimated $479K.
Symphony Financial first reported a position in Hologic in Q1 2021 and held it in 1 quarter.
Symphony Financial's Hologic position peaked at $479K in Q1 2021.
625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Symphony Financial's 13F filing for Q2 2021, filed 13 Jul 2021.